Navigation Links
ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
Date:3/11/2010

Clinical Financial Best Practices Will Be Discussed and Demonstrated at Philadelphia Conference

Chicago, IL (PRWEB) March 11, 2010 -- ClearTrial, the leading provider of Clinical Trial Operations (CTO) software, today announced it will moderate a panel discussion which includes pharmaceutical analysts from Deutsche Bank and Cowen & Company at CBI's 2010 Accounting and Reporting Congress in Philadelphia, Pennsylvania, March 16-17. This conference is attended each year by over 300 finance, accounting, audit and reporting executives seeking information about changing regulations, technical accounting guidelines, auditing strategies and financial reporting best practices.

At this year's conference, participants will hear from an unparalleled assembly of over 35 speakers representing the pharmaceutical and biotechnology industries. Michael Bruns, CFO at ClearTrial, was chosen to moderate the Wall Street Panel, "Industry Performance Review and Strategies for Communicating Key Financial Information and Disclosures" on March 17th at 9:15 am. This panel discussion will provide perspectives from Wall Street on the pharmaceutical sector and key performance indicators. Attendees will learn best practices for investor calls, financial disclosures and overall communications regarding financial positions while gaining insight on industry trends and overall industry market perception from senior life science sector industry analysts.

Prior to joining ClearTrial, Mr. Bruns founded and directed the Technology and Investment Banking group at Robert W. Baird & Co., a global investment banking firm. He led the group's business development efforts and advised executive management teams and boards of directors of public and private company clients on corporate strategy, acquisition strategy and corporate finance alternatives.

Attendees can also visit ClearTrial in the exhibit hall to see practical demonstrations of how some of the world's leading Pharmaceutical and Biotech companies are using ClearTrial as the foundation for their innovative Clinical Financial Best Practices.

By attending these demonstrations, attendees will learn how to:

 
  • Accurately track accruals and reforecast for change orders
  • Gain insight into cost variances and underperforming projects
  • Determine when to outsource
  • Recognize cost savings within collaborative arrangements
  • Anticipate study costs for both in-licensing and out-licensing agreements

CBI's 2010 Accounting and Reporting Congress event will be held at the Loews Hotel, Philadelphia, PA on March 16-17. For more information and to register for the conference, visit http://www.cbinet.com/show_conference.cfm?confcode=PC10139.

About ClearTrial®
ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, an integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial's award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

For more information contact:
Nicole Fitzmaurice
ClearTrial
+1 630.986.9800 x131
nfitzmaurice(at)cleartrial(dot)com

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3714124.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
2. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
3. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
4. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
5. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
6. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
7. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
8. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
9. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
10. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
11. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 According to a ... and derivatives market is fragmented due to the presence of a large ... Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each other ... companies, collectively, held more than 76% of this market in 2016.  ... As of now, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced ... the hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business ... joint development activities. , “Dr. Floyd’s career has spanned 30 years in the ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
Breaking Biology Technology:
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/16/2017)... Germany , March 16, 2017 CeBIT 2017 - Against identity ... Continue Reading ... Used combined in one project, multi-biometric solutions provide ... Used ... Systems) ...
Breaking Biology News(10 mins):